Quantcast
Channel: cafepharma - psoriasis
Browsing latest articles
Browse All 31 View Live

Merck says psoriasis, HDL, Alzheimer's drug trials moving ahead

Merck says psoriasis, HDL, Alzheimer's drug trials moving ahead Reuters

View Article



Can Johnson & Johnson Cash In on Stelara?

Can Johnson & Johnson Cash In on Stelara? Motley Fool

View Article

Celgene drug shown to be effective, safe in psoriasis trial

Celgene drug shown to be effective, safe in psoriasis trial Reuters

View Article

Do These Pipeline Drugs Hold the Key to AbbVie's Future?

Do These Pipeline Drugs Hold the Key to AbbVie's Future? Motley Fool

View Article

2 Sides of Celgene's Apremilast Results

2 Sides of Celgene's Apremilast Results Motley Fool

View Article


Can New Psoriasis Drugs Scratch Investors' Itch?

Can New Psoriasis Drugs Scratch Investors' Itch? Investors.com

View Article

Can Merck Field a Psoriasis Blockbuster?

Can Merck Field a Psoriasis Blockbuster? Motley Fool

View Article

Is Celgene's Apremilast A Potential Blockbuster Or Not?

Is Celgene's Apremilast A Potential Blockbuster Or Not? Seeking Alpha

View Article


Psoriasis Med Similiar To Biogen MS Pill Is Linked To Brain Disease

Psoriasis Med Similiar To Biogen MS Pill Is Linked To Brain Disease Pharmalot

View Article


Novartis' psoriasis drug superior to Enbrel in study

Novartis' psoriasis drug superior to Enbrel in study Reuters

View Article

XenoPort to continue development of XP23829 after Phase 1 results

XenoPort to continue development of XP23829 after Phase 1 results Yahoo/Fly on the Wall

View Article

New class of psoriasis drugs being developed

New class of psoriasis drugs being developed Bloomberg

View Article

Psoriasis study does little to help Pfizer with Xeljanz

Psoriasis study does little to help Pfizer with Xeljanz Fierce Pharma

View Article


Idera: A Compelling Biotech Pick For March

Idera: A Compelling Biotech Pick For March Seeking Alpha

View Article

AbbVie's Humira Still a Growth Engine

AbbVie's Humira Still a Growth Engine Motley Fool

View Article


Experimental J&J psoriasis drug shows promise in study

Experimental J&J psoriasis drug shows promise in study Yahoo/Reuters

View Article

Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib...

Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis...

View Article


Novartis' Phase III Results on Secukinumab Published

Novartis' Phase III Results on Secukinumab Published Yahoo/Zacks.com

View Article

Humira Still Key to AbbVie

Humira Still Key to AbbVie Motley Fool

View Article

Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial

Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of Clinical Trial Yahoo

View Article
Browsing latest articles
Browse All 31 View Live




Latest Images